Metastatic Lung Cancer research hub

Datopotamab Deruxtecan (Dato-DXd, DS-1062a) in Advanced and/or Unresectable Non-Small Cell Lung Cancer

This study looks at a new drug, DS-1062a, for people with advanced lung cancer that has spread or can't be removed by surgery. We want to see how well it works and if it's safe for those who haven't responded to previous treatments.